Literature DB >> 11352917

Hydrophobic as well as charged residues in both MEK1 and ERK2 are important for their proper docking.

S Stippec, F L Robinson, M H Cobb.   

Abstract

Docking between MEK1 and ERK2 is required for their stable interaction and efficient signal transmission. The MEK1 N terminus contains the ERK docking or D domain that consists of conserved hydrophobic and basic residues. We mutated the hydrophobic and basic residues individually and found that loss of either type reduced MEK1 phosphorylation of ERK2 in vitro and its ability to bind to ERK2 in vivo. Moreover, ERK2 was localized in both the cytoplasm and the nucleus when co-expressed with MEK1 that had mutations in either the hydrophobic or the basic residues. We then identified two conserved hydrophobic residues on ERK2 that play roles in docking with MEK1. Mutating these residues to alanine reduced the interaction of ERK2 with MEK1 in cells. These mutations also reduced the phosphorylation of MEK1 by ERK2 but had little effect on phosphorylation of MBP by ERK2. Finally, we generated docking site mutants in ERK2-MEK1 fusion proteins. Although the mutation of the MEK1 D domain significantly reduced ERK2-MEK1 activity, mutations of the putatively complementary acidic residues and hydrophobic residues on ERK2 did not change its activity. However, both types of mutations decreased the phosphorylation of Elk-1 caused by ERK2-MEK1 fusion proteins. These findings suggest complex interactions of MEK1 D domains with ERK2 that influence its activation and its effects on substrates.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11352917     DOI: 10.1074/jbc.M102769200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  25 in total

1.  Rac-PAK signaling stimulates extracellular signal-regulated kinase (ERK) activation by regulating formation of MEK1-ERK complexes.

Authors:  Scott T Eblen; Jill K Slack; Michael J Weber; Andrew D Catling
Journal:  Mol Cell Biol       Date:  2002-09       Impact factor: 4.272

Review 2.  The ERK cascade: a prototype of MAPK signaling.

Authors:  Hadara Rubinfeld; Rony Seger
Journal:  Mol Biotechnol       Date:  2005-10       Impact factor: 2.695

3.  Mechanisms of MAPK signalling specificity.

Authors:  L Bardwell
Journal:  Biochem Soc Trans       Date:  2006-11       Impact factor: 5.407

Review 4.  Molecular basis of MAP kinase regulation.

Authors:  Wolfgang Peti; Rebecca Page
Journal:  Protein Sci       Date:  2013-10-19       Impact factor: 6.725

5.  Chromatin-bound mitogen-activated protein kinases transmit dynamic signals in transcription complexes in beta-cells.

Authors:  Michael C Lawrence; Kathleen McGlynn; Chunli Shao; Lingling Duan; Bashoo Naziruddin; Marlon F Levy; Melanie H Cobb
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-28       Impact factor: 11.205

6.  Charged residues at protein interaction interfaces: unexpected conservation and orchestrated divergence.

Authors:  Nan Zhao; Bin Pang; Chi-Ren Shyu; Dmitry Korkin
Journal:  Protein Sci       Date:  2011-06-02       Impact factor: 6.725

7.  Endogenous, regulatory cysteine sulfenylation of ERK kinases in response to proliferative signals.

Authors:  Jeremiah D Keyes; Derek Parsonage; Rama D Yammani; LeAnn C Rogers; Chelsea Kesty; Cristina M Furdui; Kimberly J Nelson; Leslie B Poole
Journal:  Free Radic Biol Med       Date:  2017-08-24       Impact factor: 7.376

8.  An ERK2 docking site in the Pointed domain distinguishes a subset of ETS transcription factors.

Authors:  Jeffrey J Seidel; Barbara J Graves
Journal:  Genes Dev       Date:  2002-01-01       Impact factor: 11.361

9.  Differential targeting of the stress mitogen-activated protein kinases to the c-Jun dimerization protein 2.

Authors:  Sigal Katz; Ami Aronheim
Journal:  Biochem J       Date:  2002-12-15       Impact factor: 3.857

10.  GIT1 is a novel MEK1-ERK1/2 scaffold that localizes to focal adhesions.

Authors:  Ning Zhang; Weihua Cai; Guoyong Yin; David J Nagel; Bradford C Berk
Journal:  Cell Biol Int       Date:  2009-12-16       Impact factor: 3.612

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.